Central Fill Pharmacy Automation Market Share

  • Report ID: 5392
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Central Fill Pharmacy Automation Market Share

North American Market Forecast

The central fill pharmacy automation market in the North America region is projected to hold the largest revenue share of 40% by the end of 2037. One of the primary growth drivers for the market in North America is the continuously increasing prescription volume. The United States and Canada have been experiencing a rise in the demand for prescription medications, influenced by factors such as population growth, aging demographics, and the increasing prevalence of chronic diseases. This surge in prescription volume necessitates automation to efficiently manage the medication fulfillment process. In the United States, prescription drug expenditures were estimated to have reached USD 370.7 billion in 2019. Enhancing patient safety and medication accuracy is a critical driver for the adoption of central fill pharmacy automation.

APAC Market Statistics

The central fill pharmacy automation market in the Asia Pacific region is projected to hold the second largest share during the forecast period. One of the primary drivers for the market in the APAC region is the increasing demand for healthcare services. This demand is propelled by several factors, including a rapidly aging population, urbanization, and the prevalence of chronic diseases. As the demand for healthcare services surges, so does the need for efficient prescription fulfillment, making central fill pharmacy automation a critical solution. The World Health Organization (WHO) notes that Asia Pacific is experiencing an aging population, with a projected increase in the number of people aged 60 and over from 549 million in 2019 to 1.3 billion in 2050. Ensuring medication safety and accuracy is paramount in healthcare, and medication errors can have severe consequences for patients. Central fill pharmacy automation significantly reduces the risk of errors by automating the medication dispensing process, ensuring precise dosages and proper labeling. This enhances patient safety and builds trust in healthcare services. Efficiency in workflow is a crucial driver for central fill pharmacy automation in the APAC region.

Research Nester
Coumarin Market size.PNG
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5392
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of central fill pharmacy automation is evaluated at USD 745.84 million.

The central fill pharmacy automation market size was over USD 684.51 million in 2024 and is set to exceed USD 2.72 billion by the end of 2037, witnessing over 11.2% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for healthcare sector will impel the market growth.

North America industry is expected to account for largest revenue share 40% by 2037, impelled by increasing prescription volume in the region.

The major players in the market are Omnicell, Inc., McKesson Corporation, Swisslog Healthcare, ScriptPro LLC, Innovation Associates, Inc., Parata Systems, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample